AzTrials
AzTrials

Muscle WeaknessNCT04315662

Power Training on Muscle Quality and Functional Capacity in Women Aged 65-75.

A study testing Muscle power training with velocity loss (VL) of 10% and Muscle power training with velocity loss (VL) of 30% in people with Muscle Weakness and Muscle Loss, run by Universidad del Valle, Colombia at 1 site in Colombia.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Muscle power training has proven to be an effective intervention to prevent sarcopenia and frailty in old people. In the last decade, new concepts related to the functionality of old people have been generated, such as muscle quality and functional capacity. Read more about this study

Who is it for?
Ages 65 to 75 years, women onlyHealthy volunteers can take part
Conditions the study is for
Muscle Weakness, Muscle Loss
What is being tested?
Muscle power training with velocity loss (VL) of 10% and Muscle power training with velocity loss (VL) of 30%
Could I receive a placebo?
No, everyone receives an active treatment
How many people
56 participants
Where
1 siteColombia
Study dates
1 May 2020to 11 Feb 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 to 75 years
  • Women only
  • Healthy volunteers accepted
  • Older adult

Who may be able to join

  • Women 65 to 75 years.
  • Healthy volunteers.
  • Have not perform muscle power training in the last six months.

Who cannot join

  • History of asthma.
  • History of uncontrolled diabetes.
  • History of uncontrolled hypertension.
  • History of cardiovascular disease.
  • History of coronary heart disease.
  • Smoker.
Show all 11Show fewer
  • Arrhythmias.
  • Personal history of surgical procedures in the last three months.
  • Uncontrolled non-communicable diseases.
  • Psychological, sensitive, cognitive, neuromotor and/or osteo-muscular conditions that may affect participation in an exercise program.
  • Under medical treatment with anticoagulants, bronchodilators, and/or steroids.

Trial locations and contacts

1 site in 1 country.

Fredy A Patiño, Ph.D. contact

+573167849453

fredy.patino@udea.edu.co

Colombia1 site
  • Universidad del Valle

    Cali, Valle del Cauca Department

    Santiago A Arboleda, Ph.D., +573164459690, santiago.arboleda@correounivalle.edu.co

    Fredy A Patiño, Ph.D.

Other trials in Colombia

About this study

Official title: Effects of a Power Training at Two Different Loads on Muscle Quality and Functional Capacity in Women Aged 65-75.

Muscle power training has proven to be an effective intervention to prevent sarcopenia and frailty in old people. In the last decade, new concepts related to the functionality of old people have been generated, such as muscle quality and functional capacity.

The power training consists of rapid movements of short duration that imply a more specialized neuromuscular response and that improve the functional response reflected in activities of daily life that demand a certain manifestation of muscular power (stand up of a chair, climbing stairs, rebalance, accelerate suddenly, among others). Therefore, it is important to investigate the dose-response relationships in power training in older people and establish how possible improvements in muscle quality can be reflected in functional capacity.

The aim of this study is to compare the effects of power training at two different loads on muscle quality and functional capacity in women aged 65-75

Read the detailed description

Fifty-six women will be randomly assigned to one of two muscle power training supervised for a physical activity instructor with different velocity loss (VL) thresholds: 10% (VL10) and 30% (VL30). Subjects followed a muscle power training for 8 weeks (2 sessions per week on alternate days) using the leg extension exercise, with similar relative intensity (50% 1RM). Between weeks one and four two series will be performed per session. Then the number of series will increase to three per session. The inter-set recovery period will be always of 2-min.

Before and after the muscle power training the following tests will be performed: 1) measure of body composition with dual-energy x-ray absorptiometry for determining the lean mass of thighs; 2) three functional test (chair stand test, time up go test with cognitive task and gait speed test); 3)Progressive loading test in a leg extension machine until finding the mean muscle power corresponding to 50% of 1RM (speed of concentric phase of 6.67 ± 0.04 m/s measured using a camera-based optoelectronic system).

Being tested
Muscle power training with velocity loss (VL) of 10%, Muscle power training with velocity loss (VL) of 30%
Keywords
Muscle quality, Functional capacity, Power training
Medical subject headings
Muscle Weakness, Muscular Atrophy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Muscle power training with velocity loss (VL) of 10%Other

    Subjects followed a muscle power training for 8 weeks (2 sessions per week on alternate days) using the leg extension exercise, with similar relative intensity (50% 1RM). Between weeks one and four two series will be performed per session. Then the number of series will increase to three per session. The inter-set recovery period will be always of 2-min. Velocity loss will be of 10% (VL10) in each set.

  • Muscle power training with velocity loss (VL) of 30%Other

    Subjects followed a muscle power training for 8 weeks (2 sessions per week on alternate days) using the leg extension exercise, with similar relative intensity (50% 1RM). Between weeks one and four two series will be performed per session. Then the number of series will increase to three per session. The inter-set recovery period will be always of 2-min. Velocity loss will be of 30% (VL30) in each set.

Study groups in NCT04315662
Study groupRoleWhat they receive
Muscle power training with velocity loss (VL) of 10%ExperimentalSubjects followed a muscle power training for 8 weeks (2 sessions per week on alternate days) using the leg extension exercise, with similar relative intensity (50% 1RM). Between weeks one and four two series will be performed per session. Then the number of series will increase to three per session. The inter-set recovery period will be always of 2-min. Velocity loss will be of 10% (VL10) in each set.
Receives: Other: Muscle power training with velocity loss (VL) of 10%
Muscle power training with velocity loss (VL) of 30%Active comparatorSubjects followed a muscle power training for 8 weeks (2 sessions per week on alternate days) using the leg extension exercise, with similar relative intensity (50% 1RM). Between weeks one and four two series will be performed per session. Then the number of series will increase to three per session. The inter-set recovery period will be always of 2-min. Velocity loss will be of 30% (VL30) in each set.
Receives: Other: Muscle power training with velocity loss (VL) of 30%

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change on muscle quality: obtained by measuring mean leg extension power divided by muscle mass of thighs

    The muscle quality will be obtained by measuring mean leg extension power divided by muscle mass of thighs (measured by dual-energy x-ray absorptiometry)

    Measured: Baseline and after 8 weeks

Secondary outcomes (3)
  1. Change on chair stand test

    Participants stand up straight as quickly as they can five times, without stopping in between. After standing up each time, subjects will sit down and then stand up again. They will keep their arms folded across their chest. The examiner will be timing with a stopwatch.

    Measured: Baseline and after 8 weeks

  2. Change on time up go test with cognitive task

    The participant stands up from a chair, walks to the mark 3 m away, turns around, returns to the chair, and sits down again. The participants walk safely, as fast as possible. While walking, the participant counts backward in threes from a randomly chosen start number between 60 and 100 to avoid a learning effect.

    Measured: Baseline and after 8 weeks

  3. Change on gait speed test

    Participants walk a 4-m marked course at their usual walking pace, with the examiner timing their walk with a stopwatch.

    Measured: Baseline and after 8 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Mar 2020
  2. Study start1 May 2020 (estimated)
  3. Primary completion30 Nov 2020 (estimated)
  4. Study completion11 Feb 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
56 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04315662
Sponsor's protocol ID
CI5302
Status last verified
Mar 2020
First submitted
9 Mar 2020
Last updated
19 Mar 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Muscle power training with velocity loss (VL) of 10% and Muscle power training with velocity loss (VL) of 30% in people with Muscle Weakness and Muscle Loss, run by Universidad del Valle, Colombia at 1 site in Colombia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 19 Mar 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Colombia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Santiago A Arboleda, Ph.D. (+573164459690, santiago.arboleda@correounivalle.edu.co), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change on muscle quality: obtained by measuring mean leg extension power divided by muscle mass of thighs (time frame: Baseline and after 8 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Mar 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in